Antipneumocystis activity of 17C91, a prodrug of atovaquone
about
Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugsThe future of prodrugs - design by quantum mechanics methods.Prodrugs design based on inter- and intramolecular chemical processes.Computer-assisted design of pro-drugs for antimalarial atovaquone.Atovaquone-statine "double-drugs" with high antiplasmodial activity.
P2860
Antipneumocystis activity of 17C91, a prodrug of atovaquone
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Antipneumocystis activity of 17C91, a prodrug of atovaquone
@ast
Antipneumocystis activity of 17C91, a prodrug of atovaquone
@en
Antipneumocystis activity of 17C91, a prodrug of atovaquone
@nl
type
label
Antipneumocystis activity of 17C91, a prodrug of atovaquone
@ast
Antipneumocystis activity of 17C91, a prodrug of atovaquone
@en
Antipneumocystis activity of 17C91, a prodrug of atovaquone
@nl
prefLabel
Antipneumocystis activity of 17C91, a prodrug of atovaquone
@ast
Antipneumocystis activity of 17C91, a prodrug of atovaquone
@en
Antipneumocystis activity of 17C91, a prodrug of atovaquone
@nl
P2093
P2860
P356
P1476
Antipneumocystis activity of 17C91, a prodrug of atovaquone
@en
P2093
P2860
P304
P356
10.1128/AAC.39.10.2217
P407
P577
1995-10-01T00:00:00Z